Your browser is no longer supported. Please, upgrade your browser.
Settings
TEVA Teva Pharmaceutical Industries Limited daily Stock Chart
TEVA [NYSE]
Teva Pharmaceutical Industries Limited
Index- P/E- EPS (ttm)-0.76 Insider Own0.60% Shs Outstand1.09B Perf Week6.69%
Market Cap13.20B Forward P/E4.56 EPS next Y2.63 Insider Trans-2.66% Shs Float1.09B Perf Month17.49%
Income-825.00M PEG- EPS next Q0.54 Inst Own50.00% Short Float1.46% Perf Quarter-5.83%
Sales16.95B P/S0.78 EPS this Y59.40% Inst Trans-8.11% Short Ratio0.85 Perf Half Y14.78%
Book/sh12.38 P/B0.97 EPS next Y4.83% ROA-1.40% Target Price10.89 Perf Year8.33%
Cash/sh1.63 P/C7.32 EPS next 5Y3.20% ROE-6.00% 52W Range6.07 - 13.76 Perf YTD22.04%
Dividend- P/FCF31.96 EPS past 5Y-17.70% ROI-0.40% 52W High-13.08% Beta1.61
Dividend %- Quick Ratio0.70 Sales past 5Y-3.60% Gross Margin45.80% 52W Low97.03% ATR0.56
Employees40039 Current Ratio1.00 Sales Q/Q5.00% Oper. Margin-2.30% RSI (14)66.93 Volatility3.75% 4.82%
OptionableYes Debt/Eq1.93 EPS Q/Q165.40% Profit Margin-4.90% Rel Volume0.34 Prev Close12.02
ShortableYes LT Debt/Eq1.81 EarningsMay 07 BMO Payout- Avg Volume18.72M Price11.96
Recom2.90 SMA208.31% SMA5023.37% SMA20028.86% Volume6,426,424 Change-0.50%
Apr-24-20Resumed Citigroup Neutral $10
Apr-06-20Upgrade UBS Neutral → Buy $14 → $12
Feb-24-20Downgrade Edward Jones Hold → Sell
Nov-12-19Upgrade JP Morgan Underweight → Neutral $8
Oct-17-19Upgrade Gabelli & Co Hold → Buy
Aug-07-19Downgrade Evercore ISI Outperform → In-line
Jul-19-19Initiated Wolfe Research Peer Perform
Jul-15-19Downgrade Morgan Stanley Equal-Weight → Underweight
Jul-10-19Resumed Credit Suisse Neutral
Jul-05-19Upgrade Argus Hold → Buy
Jun-11-19Initiated Barclays Underweight $8
Jun-03-19Upgrade Oppenheimer Perform → Outperform $12
May-30-19Downgrade BofA/Merrill Buy → Underperform
May-28-19Downgrade UBS Buy → Neutral
Mar-20-19Initiated SunTrust Hold
Mar-07-19Resumed UBS Buy $22
Mar-06-19Downgrade Morgan Stanley Overweight → Equal-Weight $17
Feb-20-19Downgrade Mizuho Buy → Neutral $25 → $18
Feb-14-19Upgrade Raymond James Mkt Perform → Outperform $22
Jan-23-19Upgrade UBS Neutral → Buy
May-25-20 02:00AM  Teva Presented New Data at the European Academy of Neurology Congress Evaluating the AJOVY® (fremanezumab) Experience in Populations with Difficult-to-Treat Migraine Business Wire
May-22-20 05:59AM  Can Teva (TEVA) Return to Growth in This Year or Next? Zacks
02:00AM  Teva to Present New AJOVY® (fremanezumab) Analyses and Latest COPAXONE® Data (glatiramer acetate injection) at European Academy of Neurology Congress Business Wire
May-21-20 03:38PM  Teva Pharmaceutical Could Be Making a Comeback TheStreet.com
05:51AM  3 Absolutely No-Brainer Bear Market Buys Motley Fool
May-19-20 03:18PM  Johns Hopkins doctor on Trump's preventative hydroxychloroquine use: 'hopefully other people will not follow this example' Yahoo Finance Video
May-18-20 07:00AM  China Approves AUSTEDO® For Treating Chorea Associated with Huntington's Disease and Tardive Dyskinesia in Adults Business Wire
May-16-20 11:48AM  Coronavirus update: New outbreaks reported in states that plan to reopen soon, while Trump suggests testing is overrated MarketWatch
May-14-20 02:43PM  NIH to study malaria drug championed by President Trump against COVID-19 Reuters
02:37PM  Government trial to test hydroxychloroquine, antibiotic combo in COVID-19 patients MarketWatch
08:00AM  13 Stock Ideas From Top Value Managers Barrons.com
May-13-20 11:50AM  Is Teva Pharmaceutical Industries Ltd (TEVA) Stock Undervalued Right Now? Zacks
May-09-20 01:31PM  Teva Pharmaceutical Industries Limited (TEVA) Q1 2020 Earnings Call Transcript Motley Fool
May-08-20 09:56AM  Teva (TEVA) Q1 Earnings Top, Coronavirus-Led Buying Aids Sales Zacks
May-07-20 07:03PM  Teva Pharmaceutical's Q1 Earnings Beat Helps RS Rating Jump To 90 Investor's Business Daily +10.21%
05:33PM  2 Stocks With High Potential on Thursday GuruFocus.com
04:11PM  Generic-Drug Powerhouse Jumps On 'Strong Beat,' Reaffirmed Outlook Investor's Business Daily
02:52PM  Teva CEO Kare Schultz On Drugmaker's Outlook, Coronavirus Response Benzinga
02:15PM  Here's Why Teva Pharmaceuticals Jumped Higher Today Motley Fool
01:24PM  Tevas CEO on Why the Generic Drugmaker Is Confident Despite Covid-19 Barrons.com
09:07AM  Teva Soars as Generic Drugmaker Tops Earnings and Revenue Estimates TheStreet.com
08:39AM  Teva (TEVA) Q1 Earnings & Sales Beat Estimates, Stock Up Zacks
08:04AM  Teva shares soar 10% on strong revenue in first quarter MarketWatch
07:10AM  Teva Pharm Q1 profit beats forecasts, reaffirms 2020 outlook Reuters
07:00AM  Teva Reports First Quarter 2020 Financial Results Business Wire
05:00AM  Cigna's Express Scripts offers discounted drugs for U.S. newly unemployed Reuters
May-05-20 04:50PM  The Vanguard Health Care Fund Exits CVS Health, Teva Pharmaceutical GuruFocus.com
06:45AM  Will a Migraine Drug Save This Debt-Ridden Giant? Motley Fool
01:02AM  Corcept Therapeutics Incorporated (CORT) Q1 2020 Earnings Call Transcript Motley Fool
May-04-20 11:52AM  Teva (TEVA) to Report Q1 Earnings: What's in the Cards? Zacks
08:00AM  Teva and Celltrion Healthcare Announce the Launch of TRUXIMA® (rituximab-abbs) Injection for Rheumatoid Arthritis, the Only Biosimilar to Rituxan® (rituximab) Available in the United States for This Indication Business Wire
May-01-20 04:55PM  Vanguard Health Care Fund's Top 5 1st-Quarter Trades GuruFocus.com -5.59%
08:00AM  New Data For Teva AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine) Tablets Included in Neurology Business Wire
Apr-30-20 10:22AM  India exports 50 mln hydroxychloroquine tablets to US for COVID-19 fight -source Reuters
Apr-29-20 06:06AM  Got $2,000? Park It in These Top Stocks for 10 Years. Motley Fool
Apr-28-20 05:50PM  Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know Zacks
Apr-27-20 08:00AM  Teva Announces U.S. Launch of Autoinjector for AJOVY® (fremanezumab-vfrm) Injection Business Wire
Apr-16-20 06:27PM  Teva to Host Conference Call to Discuss First Quarter 2020 Financial Results at 8 a.m. ET on May 7, 2020 Business Wire
Apr-07-20 05:50PM  Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know Zacks
05:46PM  Teva Pharmaceutical Finance Netherlands II BV -- Moody's affirms Teva's Ba2 CFR; upgrades liquidity rating to SGL-2 Moody's
09:46AM  Covid-19 Could Bring Generic Drug Manufacturing Back to the U.S., Analyst Writes Barrons.com
09:45AM  Trumps personal stake in the malaria-drug maker Sanofi could be as small as $99 MarketWatch
07:30AM  Teva Canada Committed to Canadian Caregivers CNW Group
Apr-06-20 11:37AM  Teva Analyst Says Shares Are Pricing In Too Much Risk Benzinga +12.62%
Apr-05-20 10:22AM  Theres scant evidence so far for chloroquine as a COVID-19 drug but theres already a shortage MarketWatch
Apr-03-20 02:39AM  RPT-Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19 Reuters
Mar-31-20 01:27PM  U.S. court rules for Teva in migraine patent dispute with Eli Lilly Reuters +5.52%
01:09PM  U.S. court rules for Teva in migraine patent dispute with Eli Lilly Reuters
12:32PM  The Zacks Analyst Blog Highlights: Novartis, Teva, Gilead and AbbVie Zacks
Mar-27-20 06:45PM  Covid-19 Could Benefit Generic Drug Companies GuruFocus.com
01:20PM  Coronavirus Drugs Already in the Pipeline Kiplinger
Mar-26-20 05:45PM  Teva Pharmaceutical Industries Ltd. (TEVA) Gains But Lags Market: What You Should Know Zacks
Mar-24-20 05:16PM  Chloroquine, Hydroxychloroquine And Coronavirus: What You Should Know Benzinga +8.41%
09:57AM  Companies Plan to Boost Production of Controversial Malaria Drug as Demand Jumps Barrons.com
Mar-22-20 10:13AM  Trump makes the case for chloroquine as a COVID-19 treatment, though it has not been approved by the FDA for this illness MarketWatch
Mar-21-20 11:03AM  Coronavirus update: 284,566 cases, 11,868 deaths, New York and Illinois in lockdown MarketWatch
10:23AM  Good news for the stock market would be any potential treatment against the coronavirus MarketWatch
Mar-20-20 05:45PM  Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know Zacks
10:44AM  Teva Donates 6 Million Tablets of Malaria Drug to Fight Coronavirus in U.S. TheStreet.com
10:24AM  Teva donating 6 million doses of drug as potential COVID-19 treatment American City Business Journals
08:56AM  Mylan, Teva in Focus As Chloroquine Being Tested for Coronavirus Zacks
08:00AM  Benzinga Pro's Stock To Watch For Fri., Mar. 20, 2020: TEVA Benzinga
07:47AM  Teva to donate 6 million doses of hydroxychloroquine, floated as a potential treatment for COVID-19 MarketWatch
Mar-19-20 08:23PM  Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide Business Wire +7.17%
Mar-17-20 02:03PM  Here is What Hedge Funds Think About Teva Pharmaceutical Industries (TEVA) Insider Monkey
Mar-16-20 08:00AM  Teva and Celltrion Healthcare Announce U.S. Availability of HERZUMA® (trastuzumab-pkrb) for Injection Business Wire -14.88%
Mar-12-20 03:30AM  Positive Recommendation by NICE for first anti-CGRP migraine therapy: AJOVY® (fremanezumab) Business Wire -13.43%
Mar-10-20 02:52PM  Closely watched opioid trial in New York postponed due to coronavirus Reuters +5.52%
Mar-03-20 04:43PM  Indian Authorities Cut Some Drug Exports Barrons.com
09:53AM  CORRECTED-Roche pushes to kick-start lung therapy Esbriet after big writedown Reuters
Feb-28-20 10:07AM  Confounding Decline Creates an Opportunity in Amarin Stock InvestorPlace -5.57%
09:07AM  FDA Reports First Drug Shortage Due to Coronavirus, Far Earlier Than Expected Barrons.com
Feb-27-20 06:11PM  Biohaven drug wins U.S. FDA approval for use in relieving migraine headaches Reuters -6.22%
01:12PM  Opioid companies say lawyers' fee demand threatens settlement talks Reuters
Feb-26-20 01:03PM  Stocks To Watch: Teva Pharmaceutical Sees Relative Strength Rating Rise To 94 Investor's Business Daily
Feb-25-20 04:27PM  Mallinckrodt Unveils $1.6 Billion Opioid Deal And Generic Stocks Pop Investor's Business Daily
10:14AM  US STOCKS- Wall Street edges higher a day after sharp sell-off Reuters
08:23AM  US STOCKS- Positive earnings boost futures after Monday's selloff Reuters
Feb-24-20 12:41PM  The Zacks Analyst Blog Highlights: Johnson & Johnson, Bayer Aktiengesellschaft, Pfizer, Mylan N.V. and Teva Pharmaceutical Industries Zacks
12:25PM  Sanofi Plans Spinoff of Manufacturing Facilities Barrons.com
08:00AM  Teva Announces FDA Approval of ArmonAir® Digihaler (fluticasone propionate) Inhalation Powder Business Wire
Feb-21-20 07:37PM  U.S. FDA approves Lundbeck's migraine prevention therapy Reuters
09:16AM  3 Best Drugmakers That Are Immune to Coronavirus Fright Zacks
Feb-20-20 07:06AM  The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study Benzinga
Feb-14-20 07:10AM  Positive Earnings Look as If Theyre Already Priced in to Teva Stock InvestorPlace
Feb-13-20 02:42PM  Leaner, More Agile Teva Sees Brighter Days Ahead GuruFocus.com -6.54%
01:31PM  3 Analysts Dissect Teva's Q4 Results Benzinga
08:53AM  Teva (TEVA) Q4 Earnings In Line, Stock Up as Sales Stabilize Zacks
Feb-12-20 05:19PM  US Indexes Continue Rally Wednesday GuruFocus.com +9.08%
04:50PM  Teva Pharmaceutical CEO on Bringing His Company Back From the Brink Barrons.com
04:14PM  Why Drug Giant Teva Pharma Just Rocketed Into A Profit-Taking Zone Investor's Business Daily
02:16PM  Teva Pharmaceuticals Overtakes Key Level Post-Earnings Schaeffer's Investment Research
09:41AM  Teva Pharmaceutical Jumps After Earnings Meet Wall Street Estimates TheStreet.com
09:05AM  Teva (TEVA) Q4 Earnings In Line, Sales Beat, Stock Up Zacks
08:34AM  Teva Stock Jumps After Reporting Earnings. What You Need to Know. Barrons.com
07:56AM  Teva Reports Q4 Earnings Beat Benzinga
07:35AM  Teva's stock falls on earnings; Copaxone sales tumble 26% MarketWatch
07:30AM  New Report Shows Teva Generic Medicines Saved US Healthcare System $41.9 Billion Business Wire
07:09AM  Teva Pharm Q4 profit tops estimates by one cent Reuters
12:55AM  Teva sees higher margins, lower debt from restructuring Financial Times
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, the company provides specialty medicines for use in central nervous system and respiratory indications. Further, its products in the central nervous system and pain area comprise Copaxone for the treatment of relapsing forms of MS; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. Additionally, the company's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Braltus, Cinqair/Cinqaero, and AirDuo RespiClick/ArmonAir RespiClick/AirDuo Digihaler for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. It has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Griffin Deborah AChief Accounting OfficerMar 17Sale7.169446,7620Mar 19 08:09 AM
Stark David MatthewExec. VP Chief Legal OfficerMar 17Sale7.162,35916,8992,974Mar 19 07:38 AM
O'Grady Brendan P.EVP, North America CommercialMar 17Sale7.164703,36714,868Mar 19 07:37 AM
Nazzi GianfrancoEVP, International MarketsMar 17Sale7.173452,47419,844Mar 19 07:36 AM
Fridriksdottir HafrunExecutive VP, Global R&DMar 17Sale7.165143,68245,561Mar 19 07:33 AM
Daniell RichardExec. VP, European CommercialMar 17Sale7.176164,41810,400Mar 19 07:31 AM
Griffin Deborah AChief Accounting OfficerMar 04Sale11.234,80753,9800Mar 05 08:16 AM
O'Grady Brendan P.EVP, North America CommercialMar 03Sale11.374635,26214,159Mar 05 08:13 AM
Nazzi GianfrancoEVP, International MarketsMar 03Sale11.775486,44819,315Mar 05 08:11 AM
Daniell RichardExec. VP, European CommercialMar 03Sale11.7799111,6609,719Mar 05 08:07 AM
Griffin Deborah AChief Accounting OfficerMar 03Sale11.371,16613,2530Mar 04 06:39 AM
Griffin Deborah AChief Accounting OfficerMar 02Sale11.602,94134,1120Mar 04 06:39 AM
Drape EricExecutive VP Global OperationsFeb 19Sale12.518,000100,08021,494Feb 20 07:17 PM
Fridriksdottir HafrunExecutive VP, Global R&DFeb 14Sale12.1411,472139,29545,061Feb 18 07:23 AM
Drape EricExecutive VP Global OperationsFeb 14Sale12.148,14098,78529,494Feb 18 07:22 AM
Stark David MatthewExec. VP Chief Legal OfficerFeb 14Sale12.1417,016206,6122,974Feb 18 07:26 AM
Sabag MarkSee "Remarks" belowFeb 13Sale13.0372,131939,7600Feb 18 07:25 AM
Stark David MatthewExec. VP Chief Legal OfficerFeb 10Sale12.2412,538153,4712,974Feb 11 07:06 AM
O'Grady Brendan P.EVP, North America CommercialFeb 10Sale12.274,79958,88413,456Feb 11 07:02 AM
Nazzi GianfrancoEVP, Growth Markets CommercialFeb 10Sale12.244,15550,86418,464Feb 11 07:01 AM
Fridriksdottir HafrunExecutive VP, Global R&DFeb 10Sale12.275,54468,02533,330Feb 11 06:57 AM
Drape EricExecutive VP Global OperationsFeb 10Sale12.243,14438,48820,618Feb 11 06:56 AM
Dethlefs SvenEVP Global Marketing&PortfolioFeb 10Sale12.275,66969,55918,061Feb 11 06:53 AM
Daniell RichardExec. VP, European CommercialFeb 10Sale12.246,19975,8868,612Feb 11 06:52 AM
Fridriksdottir HafrunExecutive VP, Global R&DDec 31Sale9.922,45924,39622,754Jan 02 06:08 AM
Fridriksdottir HafrunExecutive VP, Global R&DDec 02Sale10.494,31045,21420,573Dec 03 06:32 AM
McClellan Michael JamesEVP, Chief Financial OfficerNov 05Sale8.832422,13815,898Nov 06 06:46 AM
Nazzi GianfrancoEVP, Growth Markets CommercialSep 18Sale7.829627,52310,678Sep 20 07:19 AM
O'Grady Brendan P.EVP, North America CommercialSep 18Sale7.834943,8692,135Sep 20 07:19 AM
McClellan Michael JamesEVP, Chief Financial OfficerSep 18Sale7.831,40611,01115,445Sep 20 07:17 AM
Griffin Deborah AChief Accounting OfficerSep 18Sale7.832,37618,6070Sep 20 07:12 AM
Daniell RichardExec. VP, European CommercialSep 18Sale7.821,1769,1971,676Sep 20 07:10 AM
Daniell RichardExec. VP, European CommercialSep 09Sale7.163332,384363Sep 11 06:58 AM
BARER SOL JDirectorJun 04Buy9.60104,5001,003,409220,442Jun 05 07:02 AM
BARER SOL JDirectorJun 03Buy8.98111,000997,013115,942Jun 03 11:21 AM